Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash from Discontinued Operations (2017 - 2019)

Historic Cash from Discontinued Operations for Healthstream (HSTM) over the last 4 years, with Q4 2019 value amounting to $93000.0.

  • Healthstream's Cash from Discontinued Operations rose 940000.0% to $93000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.1 million, marking a year-over-year decrease of 9303.78%. This contributed to the annual value of $2.1 million for FY2019, which is 9303.81% down from last year.
  • According to the latest figures from Q4 2019, Healthstream's Cash from Discontinued Operations is $93000.0, which was up 940000.0% from $340000.0 recorded in Q3 2019.
  • Healthstream's 5-year Cash from Discontinued Operations high stood at $31.0 million for Q1 2018, and its period low was -$1.5 million during Q2 2018.
  • Moreover, its 3-year median value for Cash from Discontinued Operations was $404500.0 (2017), whereas its average is $3.4 million.
  • Its Cash from Discontinued Operations has fluctuated over the past 5 years, first crashed by 1165384.62% in 2018, then skyrocketed by 940000.0% in 2019.
  • Over the past 3 years, Healthstream's Cash from Discontinued Operations (Quarter) stood at $798000.0 in 2017, then tumbled by 100.13% to -$1000.0 in 2018, then soared by 9400.0% to $93000.0 in 2019.
  • Its Cash from Discontinued Operations stands at $93000.0 for Q4 2019, versus $340000.0 for Q3 2019 and $1.6 million for Q1 2019.